The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model

Herpes simplex virus (HSV) infections are common and can cause severe illness but no vaccine is currently available. The recent failure of subunit HSV vaccines has highlighted the need for vaccines that present a diverse array of antigens, including the development of next-generation live-attenuated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein, David I., Cardin, Rhonda D., Smith, Gregory A., Pickard, Gary E., Sollars, Patricia J., Dixon, David A., Pasula, Rajamouli, Bravo, Fernando J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648054/
https://www.ncbi.nlm.nih.gov/pubmed/33298966
http://dx.doi.org/10.1038/s41541-020-00254-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648054/
https://www.ncbi.nlm.nih.gov/pubmed/33298966
http://dx.doi.org/10.1038/s41541-020-00254-8

Ejemplares similares